scholarly journals Continuous glucose monitoring and insulin pump therapy in pregnant women with type 1 diabetes mellitus

2021 ◽  
Author(s):  
Izabela Lason ◽  
Katarzyna Cyganek ◽  
Przemyslaw Witek ◽  
Bartlomiej Matejko ◽  
Maciej T. Malecki ◽  
...  
2013 ◽  
Vol 62 (3) ◽  
pp. 77-82 ◽  
Author(s):  
Vladimir Vsevolodovoch Potin ◽  
Natalia Viktorovna Borovik ◽  
Alena Viktorovna Tiselko

The article describes the principles of using the insulin pump therapy in patients with type 1 diabetes mellitus during pregnancy. There were obtained data about the state of the carbohydrate metabolism in pregnant women with type 1 diabetes using insulin pump therapy regimen (PI) and multiple daily insulin injections, the outcomes of pregnancy and labor.


2019 ◽  
Vol 2 (1) ◽  
pp. 20-21
Author(s):  
Jan Broz ◽  
Denisa Janickova Zdarska ◽  
Michal Policar ◽  
Viera Donicova ◽  
Marek Brabec ◽  
...  

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 701-P
Author(s):  
DAVID N. O’NEAL ◽  
NISHA VENKATESH ◽  
KATRIN BROWN ◽  
ELIF I. EKINCI ◽  
SPIROS FOURLANOS ◽  
...  

2020 ◽  
Vol 11 (12) ◽  
pp. 2993-3001
Author(s):  
Yousef Al-Saleh ◽  
Fajr Al Motairi ◽  
Esra Hassan ◽  
Abdullah Al Sohaim ◽  
Ibtisam Al Anazi ◽  
...  

2019 ◽  
Vol 24 (2) ◽  
pp. 99-106
Author(s):  
Michelle Condren ◽  
Samie Sabet ◽  
Laura J. Chalmers ◽  
Taylor Saley ◽  
Jenna Hopwood

Type 1 diabetes mellitus has witnessed significant progress in its management over the past several decades. This review highlights technologic advancements in type 1 diabetes management. Continuous glucose monitoring systems are now available at various functionality and cost levels, addressing diverse patient needs, including a recently US Food and Drug Administration (FDA)–approved implantable continuous glucose monitoring system (CGMS). Another dimension to these state-of-the-art technologies is CGMS and insulin pump integration. These integrations have allowed for CGMS-based adjustments to basal insulin delivery rates and suspension of insulin delivery when a low blood glucose event is predicted. This review also includes a brief discussion of upcoming technologies such as patch-based CGMS and insulin-glucagon dual-hormonal delivery.


PLoS ONE ◽  
2016 ◽  
Vol 11 (3) ◽  
pp. e0150604 ◽  
Author(s):  
Markus Laimer ◽  
Andreas Melmer ◽  
Julia K. Mader ◽  
Ingrid Schütz-Fuhrmann ◽  
Heide-Rose Engels ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document